Fair-Value Report — 5100 Xizang Glacier Company Limited (1115.HK)
1. The Insider Signal
Reason code: 1101 — on-exchange purchase (genuine open-market buying, not a placing/subscription).
Transaction: 90,240,000 shares bought on 25 September 2026, lifting the long position from 400,000,000 shares (7.10%) to 490,240,000 shares (8.71%) — a +1.61pp stake increase. Filing ID CS20260925E00373. Average price was not disclosed on the DI form; at the day's market price (~HK$0.49–0.50) the trade was worth roughly HK$44–45m.
This reads as a genuine, sizeable accumulation by a real, economically-interested fund manager (not a broker, custodian, nominee, or nameless trust) — it clears the bar as a signal worth valuing. Note "Harvest International Capital Management" is unrelated to the much larger PRC state-linked "Harvest Fund Management Co., Ltd." (a common name-confusion in screening data); no confirmation of an SFC Type 9 licence for this specific entity was found in public search results, which is worth independent confirmation before sizing any position off this signal.
2. Verified Snapshot
FX: CNY/HKD ≈ 1.17 (late Sep 2026). Company reports in RMB (PRC operations); share price and market cap trade in HKD on HKEX.
3. Business
5100 Xizang Glacier (renamed from Tibet Water Resources in October 2025) bottles and sells premium Tibetan glacial-source water under the "5100" brand and Highland Barley beer, alongside a smaller money-lending sideline in Hong Kong. Revenue and gross margin both stepped up sharply in FY2025 (gross margin 27.1% → 50.1%) and momentum continued into H1 2026 (RMB75m operating profit in six months versus RMB78.5m for all of FY2025) — a genuine, not merely base-effect, operational improvement.
The company carries a checkered history: it was the target of fraud allegations from short-sellers Iceberg Research and Flaming Research in 2017 (denied by the company; never proven; PwC remained auditor until 2020). It has posted large losses in two of the last three fiscal years — a RMB353m loss in FY2023 and a RMB574m loss in FY2024, the latter driven by a ~RMB460m one-off impairment on equity-accounted associates. FY2025's return to profit is only one clean year against that backdrop. Current auditor is HLB Hodgson Impey Cheng, a recognized mid-tier HK firm.
4. Valuation
Method: Given a single clean profitable year sitting on top of two years of large losses (one-off impairment-driven), this is treated as a turnaround / story-pivot rather than a stable earner — an asset-anchored (P/B) approach with scenario optionality is used rather than a formal multi-year DCF, which would over-fit to one non-representative earnings year.
| Metric | Value | Basis |
|---|---|---|
| Total equity (FY2025, consolidated) | RMB 2,874m | stockanalysis.com balance sheet |
| Book value / share | ≈RMB 0.52 (≈HK$0.61) | ÷5.56bn shares, ×1.17 FX |
| Current price / book | ≈0.80–0.85x | HK$0.49 vs ≈HK$0.61 BVPS |
| TTM net income | RMB 121.4m | stockanalysis.com |
| TTM P/E (annualized) | ≈19x | mkt cap ÷ (TTM NI × FX) |
| FY2025-only trailing P/E | ≈29x | mkt cap ÷ (FY25 NI × FX) — distorted by thin base year |
Scenario table (12-month view)
| Scenario | Narrative | Implied P/B | Fair Value (HK$) |
|---|---|---|---|
| Bear | CB fails to refinance/converts to distress; dilution + write-downs erase most of book equity cushion | 0.5x | 0.36 |
| Base | CB refinanced/extended; growth trend (rev +50–60%, GM ~45–50%) partly sustains; modest dilution from options/CB conversion | 0.85–1.0x | 0.50–0.58 |
| Bull | Turnaround proves durable across a second clean year; re-rates toward peer P/B with brand premium re-established | 1.3x | 0.79 |
| Probability-weighted | 30/50/20 | – | ≈0.53 |
Reverse read
At HK$0.49 the market is pricing this roughly in line with book value discounted for going-concern/dilution risk, and roughly in line with sector peers on a TTM-earnings basis — i.e., the market is not obviously mispricing the turnaround, it is fairly discounting the CB maturity risk and the thin one-year track record. The insider signal (a real fund buying on-exchange into 8.71%) suggests someone with more information than public filings believes the near-term CB risk resolves without severe dilution/write-down — but that belief is not yet confirmed by any public announcement.
Peer table (HK-listed water/beer, median-anchored)
| Company | Mkt Cap | P/E | Notes |
|---|---|---|---|
| Tsingtao Brewery (0168.HK) | HK$67.4bn | 12.7x | Large-cap, profitable, dividend payer |
| China Resources Beer (0291.HK) | HK$59.7bn | 18.8x | Large-cap, profitable |
| Vitasoy International (0345.HK) | HK$6.7bn | 25.1x | Small/mid-cap beverage, stable earner |
| Median peer | — | 18.8x | — |
| 5100 Xizang Glacier (1115.HK) | HK$2.7bn | ≈19x (TTM) / ≈29x (FY25) | Micro-cap, one clean year, CB overhang |
Peer set is scale-mismatched (1115 is a micro-cap versus large national brewers/bottlers) — shown for multiple context only, not a direct comp. No true HK-listed micro-cap water/beer peer with a comparable risk profile was identified; this is flagged as a data limitation.
5. Conclusion
Rating: Speculative Buy, fair value HK$0.50–0.58 (probability-weighted ≈HK$0.53) vs HK$0.49 close on 25 Sep 2026 — modest upside, wide dispersion. The insider signal is genuine (real fund, real on-exchange buying, meaningful stake increase) and coincides with a real operational inflection (margin expansion, revenue growth sustained into H1 2026). But this is not a high-conviction call: it rests on one clean profitable year following two years of large losses, and the thesis can be overwhelmed within days by how the HK$297m convertible bond maturing 5 October 2026 is resolved against a cash balance of only ~RMB7.6m. Position sizing should reflect binary-event risk around that date.
6. Key Risks
- Convertible bond maturity (5 Oct 2026): HK$297m principal + 5% accrued interest due against a cash position of only ~RMB7.6m (30 Jun 2026). Conversion price HK$0.55 is above the current HK$0.49 share price, so conversion is not currently attractive to bondholders — cash redemption, refinancing, or a restructuring/extension is more likely, any of which could be dilutive or credit-negative.
- Dilution overhang: up to 233.33m distributor share options exercisable at HK$0.60 (~4.2% of shares) plus up to ~540m shares issuable on full CB conversion (~9.7%) — combined potential dilution approaching 14% of current shares outstanding.
- Thin earnings track record: FY2025's RMB86.2m profit is the only clean profitable year in the last three, against RMB353m and RMB574m losses in FY2023 and FY2024 respectively (the latter driven by a ~RMB460m one-off associate impairment).
- Governance/reputational overhang: unresolved 2017 fraud allegations from short-sellers (never proven, but never fully vindicated either) and a 2025 corporate rebrand away from the "Tibet Water Resources" name.
- Rising leverage: total debt grew from ~RMB569m (FY2025) to ~RMB694m (TTM to mid-2026) while cash fell sharply over the same period.
- Buyer motive is opaque: as a fund manager rather than a company insider or strategic party, Harvest International's economic conviction is real but its specific information edge (if any) on the CB resolution is not disclosed.
- Micro-cap liquidity/data limits: thin analyst coverage, wide bid-ask spreads likely, and no verified peer with a matching risk/size profile.
Sources
- HKEX Disclosure of Interests filing CS20260925E00373, 25 Sep 2026 (di.hkex.com.hk)
- stockanalysis.com — 1115.HK price, financials, balance sheet (accessed 28 Sep 2026)
- Company FY2025 annual results coverage (TipRanks/company announcements, revenue/margin/net income figures)
- Company H1 2026 interim brief (revenue/operating profit)
- GMT Research "Tibet Water (1115 HK) — Tip of the Iceberg" (Oct 2017); Yicai Global coverage of Iceberg Research allegations and company rebuttal
- Company convertible bond placement announcements (Sep–Oct 2025, HK$297m, 5% coupon, HK$0.55 conversion price, maturity 5 Oct 2026)
- Simply Wall St, stockanalysis.com peer data for Tsingtao Brewery (0168.HK), China Resources Beer (0291.HK), Vitasoy International (0345.HK)
Not investment advice. This is an independent, automated research note produced for informational purposes only and does not constitute a recommendation to buy or sell any security. The author holds no position in 1115.HK. Several figures (book value attribution between owners and non-controlling interests, precise FX-converted balance sheet items, and current status of the convertible bond) rely on third-party financial-data aggregators rather than a direct read of the primary HKEX annual report PDF, which could not be retrieved in readable form at the time of writing — readers should verify against the company's primary filings before acting, particularly given the imminent bond maturity.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.